Fujifilm's EN-840T Double Balloon Enteroscopy Scope Wins 2025 MedTech Breakthrough Award
LEXINGTON, Mass.--(BUSINESS WIRE)-- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, announced that its EN-840T Double Balloon Enteroscopy (DBE) Scope, an endoscopic imaging technology that enables access to the entire small intestine for diagnosis and therapeutic intervention, has been selected as the winner of the 'Best New Endoscopy Technology Solution' award in the 9th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
The EN-840T DBE scope represents a major update to Fujifilm's pioneering Double Balloon Enteroscopy technology. The EN-840T DBE scope features several compelling features, including its ability to allow for blood or mucus to be aspirated while a therapeutic device is inserted, enabling quicker hemostasis. The scope also provides a dedicated forward water jet channel for irrigation and enables clinicians to quickly clear debris like blood on the mucous membranes for clearer visualization of the bowel wall.
'As a company with a history of 'firsts' in the endoscopy field, we're honored to be recognized by MedTech Breakthrough for our ergonomically designed EN-840T DBE scope,' said Tai Fujita, general manager of endoscopy and vice president, FUJIFILM Healthcare Americas Corporation. 'Approximately 2.39 million Americans have Inflammatory Bowel Disease (IBD), which includes Crohn's disease and ulcerative colitis. Left undiagnosed and untreated, these diseases can lead to serious complications. We're proud to offer clinicians a tool that will help them access difficult to reach pathways within the digestive tract, enabling them to more effectively diagnose and treat a wide array of small intestine diseases, gastrointestinal bleeding, and removal of small bowel polyps.'
A CMOS (Complementary Metal-Oxide-Semiconductor) image sensor in the EN-840T DBE scope ensures vivid, HD, high-quality images, providing speed and clarity for diagnosis. The scope also leverages LED multi-light technology along with Fujifilm's Linked Color Imaging (LCI)® and Blue Light Imaging (BLI) modes to provide endoscopists with enhanced visualization and enable optimal detection during small bowel procedures. The EN-840T DBE scope also provides adaptive bending and advanced force transmission technology for improved access and scope maneuverability in challenging anatomy.
'Fujifilm is both setting and elevating the gold standard in small bowel access for diagnosis and treatment. In gastrointestinal (GI) endoscopy, access is often challenged by difficult to reach pathways within the digestive tract,' said Steve Johansson, managing director, MedTech Breakthrough. 'With the EN-840T, endoscopists and GI physicians now have access to a new, novel tool to help combat this anatomical challenge and enable optimal detection during small bowel procedures, empowering them to truly push the envelope for deep small bowel diagnostics and therapeutics.'
The MedTech Breakthrough Awards program celebrates excellence and innovation in the health and medical technology industry, recognizing the companies, products, and solutions driving meaningful progress and improving patient care. This year's program attracted more than 4,500 nominations from over 18 different countries throughout the world.
To learn more about Fujifilm's EN-840T DBE scope, click here.
About Fujifilm
FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm's innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.
The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.
FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of 'giving our world more smiles,' we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
4 hours ago
- Forbes
Agfa Launches Three New Digital Photo Products All Ready For A Summer Of Fun
The new Agfa Realkids Cam Waterproof 2 is designed for kids and can shoot stills and videos. For more than a century, the photographic market has been dominated by three big brands. First came Kodak, the granddaddy of them all, founded in Rochester, New York, in 1892. Its yellow, black and red branding is still one of the most recognizable in the world. However, strong competition from Japan's Fujifilm, a relative upstart founded in 1934, put pressure on Kodak in the late 1990s pushing it to the brink of bankruptcy in 2011. Today the brand goes on but the brand is often licensed to third parties producing photographic products for the digital age. The third dominant force in photography was Agfa-Gevaert, a Belgian German company founded in 1867 as a dye manufacturer. The company endured a chequered history, especially during World War II. Like Kodak today, the name is often licensed to several businesses producing digital photography products that want to leverage such a well-known brand. Now the Agfa name is back in the photography business with a trio of fun, new products that could keep the kids happy during the long summer holidays. The first is the new Realkids Cam Waterproof 2. The Realkids Cam Waterproof 2 from Agfa has a 2.8-inch color display and speaker. FEATURED | Frase ByForbes™ Unscramble The Anagram To Reveal The Phrase Pinpoint By Linkedin Guess The Category Queens By Linkedin Crown Each Region Crossclimb By Linkedin Unlock A Trivia Ladder While it's hardly the snappiest name, there's no doubt what it is and what it does. The little waterproof camera has a colorful and child-friendly design and takes HD photos and videos. It has two lenses and includes a 2.8-inch color display for lining up the shots. The Agfa Realkids Cam Waterproof 2 can resist a plunge in the water down to 3 meters or 10 feet; we're talking paddling pool duty here rather than scuba diving. The camera is powered by a 1,200mAh rechargeable lithium battery and provides resolutions up to 12 megapixels with videos topping out at 1080p/2.7k. The camera has a slot for a 128GB microSD card and records images as JPEGs and movies as MOV. There is a selfie mode and a selection of built-in digital filters for adding a little personality to the shots. There are also some games onboard for long car journeys and a speaker for the sound effects. The Agfa Realmove MC3X is a mini gimbal camera for making videos on the move. The next new product to bear the brand is the Agfa Realmove MC3X, a mini gimbal camera for making videos on the move. The MC3X shoots in 4K resolution and has 3-axis stabilization for smooth and handheld shooting. This pocket-sized camera and gimbal delivers pro-quality footage and is suitable for shooting scenic landscapes or action. As well as shooting videos, the camera can also take still images with resolutions of up to 20 megapixels in JPEG format. The lens has a wide 120-degree view and includes Wi-Fi support. All videos and images recorded by the MC3X are stored on a microSD card. The camera's memory card slot can take cards up to 512GB. The 1,450mAh rechargeable lithium battery can last for 170 minutes of continuous shooting. Other features include a mini-HDMI output and a 3.5mm microphone input. The Agfa Realipix Mini P.2 portable photo printer is battery-powered and prints high-quality color ... More photos without the need for ink. The final product of the trio is the Agfa Realipix Mini P.2 portable photo printer. The battery-powered gadget and print high-quality color photos without the need for ink. It has a Bluetooth connection and is compatible with iOS and Android devices. Using Zink printing technology, the Realipix Mini P.2 portable photo printer produces 5 x 7.6cm or 2 x 3-inch color photos. Weighing just 189g, the lightweight printer includes digital filters and editing functions for embellishing images. The Agfa Realkids Cam Waterproof 2 is available now and costs £58.37 / €69,99. The Agfa Realmove MC3X mini gimbal camera is also available now and priced at £291.86 / €349,99. Finally, the Agfa Realipix Mini P.2 portable photo printer is shipping now and costs £52.53 / €62,99.
New York Post
a day ago
- New York Post
Joe Rogan among the fans of revolutionary anti-aging peptide
Highway to heal? An experimental peptide is in the spotlight for its potential to promote tissue repair, reduce inflammation and protect gut health. Count podcast host Joe Rogan, 57, among the fans of BPC-157 — he reported that it cleared up his elbow tendonitis in just two weeks. Biohackers hope its regenerative and anti-inflammatory powers lead to longer, healthier lives. 5 Podcast host Joe Rogan said BPC-157 cleared up his elbow tendonitis in just two weeks. Youtube / The Joe Rogan Experience 'The people who have tried it say it is life-changing,' Dr. Michael Aziz, an internist in New York and author of 'The Ageless Revolution,' told The Post. 'So is BPC-157 going to revolutionize physical therapy?' he mused. 'We hope the research comes soon.' Here's a look at the science behind the emerging therapy. What is BPC-157? BPC-157 is the short name for Body Protection Compound 157. It's comprised of 15 amino acids and derived from a naturally occurring protein in human stomach juice. Dr. Christian Muller, a sports medicine physician with Northwell Health Orthopedics in Westchester, said BPC-157 was discovered in the early '90s during research into substances that could protect the body from harm. 5 BPC-157 is in the spotlight for its potential to promote tissue repair, reduce inflammation and protect gut health. Amazon How it exactly works in the body is not fully understood. 'Research suggests BPC-157 may work by enhancing the formation of new blood vessels, which improves blood flow and nutrient delivery to injured tissues, accelerating healing,' Aziz said. 'It also influences the expression of various growth factors, such as growth hormone receptors, which are crucial for tissue repair and regeneration,' he added. Inside the potential benefits The Food and Drug Administration has not approved BPC-157, as much of the research has been conducted in animals. 'There are few, extremely limited studies on humans,' Muller told The Post. 'One study showed that knee injections with BPC-157 helped with arthritis pain in 11 out of 12 subjects, but the study did not use verified survey tools to obtain reliable answers regarding efficacy.' 5 BPC-157 may be able to help with recovery after a knee injury. Dragana Gordic – BPC-157 is being explored for: Tissue repair Healing of muscle, tendon, ligament and skin wounds Collagen production Neuroinflammation Nerve regeneration Arthritis Gastric ulcers Inflammatory bowel disease (Crohn's disease, ulcerative colitis) Leaky gut syndrome Irritable bowel syndrome 'Had a recent knee surgery? Had an injury at the gym and your doctor suggested physical therapy for six months? Not so fast. BPC-157 can help,' Aziz said. How much should you take? Dr. Pooja Gidwani, a double board-certified internal and obesity medicine physician based in L.A., noted that there are no standard doses because human data is limited. She suggested that oral forms of BPC-157 may be helpful for gut issues, while injections are typically preferred for systemic healing, such as joint or tendon recovery. She has 'nuanced conversations' with patients eager to try it. 5 How BPC-157 exactly works in the body is not fully understood. Research suggests that it may accelerate healing by enhancing the formation of new blood vessels. Sanhanat – 'We begin with an open, informed discussion about the current evidence — what's promising and what's unknown,' Gidwani told The Post. 'For some patients dealing with chronic gut issues, tendon injuries or post-operative healing challenges,' she continued, 'we discuss where the science currently stands and make a collaborative decision based on goals, risk tolerance and alternatives.' Some researchers recommend cycling it to prevent side effects. Andrew Huberman, a neuroscientist and professor of neurobiology and ophthalmology, suggests limiting BPC-157 usage to eight weeks and taking an eight-week break — or more. 'My concern about taking BPC157 continuously: it promotes vascular growth, and if you have a small tumor, it will vascularize that tumor as well. Not good,' Huberman tweeted in April. And beware if you purchase capsules online. 'Many times it is fake or not safe,' Aziz advised. Behind the possible downsides 'There are potential safety concerns, but given the lack of human data, they are not truly known,' Muller said. 'Since BPC-157 has been shown to be biologically active in several complex body processes,' he added, 'there can be a multitude of unknown potential dangers across several organ systems.' 5 New blood vessel growth may help promote healing, but it could also fuel tumors. phonlamaiphoto – Since it can cause uncontrolled growth of new blood vessels, people with a history of cancer or concerns about tumors should approach BPC-157 with caution. Because it has been shown to interact with growth hormone pathways, Aziz warned of potential hormonal disruption with extended use. It's also on the World Anti-Doping Agency's prohibited list for professional athletes because of its unproven claims and possible health risks. Scientists hope to learn more about it soon. 'Peptides like BPC-157 are part of an exciting frontier in longevity and regenerative medicine — but they're still evolving,' Gidwani said. 'It's not about hype — it's about understanding the potential while also respecting the limitations of what we know.'
Business Wire
2 days ago
- Business Wire
AM Batteries Opens Doors to Customers, Expediting Electrode Sales for Next Generation Batteries
BILLERICA, Mass.--(BUSINESS WIRE)--AM Batteries, a pioneer in dry battery electrode (DBE) technology, opened its state-of-the-art Customer Success Center Monday, enabling the development of next-generation batteries with advanced manufacturing technology. AM Batteries' new facility will play a crucial role in ongoing efforts to secure the U.S. battery manufacturing supply chain. The ribbon-cutting ceremony was attended by U.S. Representative Lori Trahan (D-MA) and Massachusetts' Interim Secretary of Economic Development Ashley Stolba. AM Batteries has developed an advanced process for the manufacturing of electrodes, a critical component in any battery. The company's proprietary Powder to Electrode™ dry coating method enables 30% lower capital costs, 50% lower operating costs, 45% less energy consumption, and a 5x smaller factory footprint compared to conventional wet coating methods. AM Batteries equips battery manufacturers of all sizes with turnkey manufacturing systems — from custom electrodes to specialized equipment to deep process expertise. "Our dry-electrode process helps battery manufacturers dramatically reduce costs without sacrificing quality and performance,' said Lie Shi, CEO of AM Batteries. 'With the opening of this facility, we're entering a new chapter—one that supports both AMB's growth and the American battery revival.' AM Batteries' dry battery electrode technology is chemistry agnostic, providing customers unprecedented flexibility to test a plethora of materials in this dry-room environment. This flexibility allows manufacturers to use different chemistries, such as moisture-sensitive high-nickel cathode materials that have been shown to extend electric transportation ranges and allow defense drones to operate longer in extreme temperatures. 'The opening of AM Batteries' new Customer Success Center marks a major milestone in strengthening our domestic battery supply chain and creating good-paying, future-ready jobs right here in Billerica,' said Congresswoman Lori Trahan of Massachusetts' third district. 'By investing in cutting-edge clean energy technologies like dry electrode manufacturing, AM Batteries is helping to position Massachusetts – and the United States – as a global leader in next-generation battery innovation.' 'The opening of AM Batteries' Customer Success Center is a testament to Massachusetts' leadership in fostering innovation and creating a thriving ecosystem for advanced manufacturing,' said Interim Secretary of Economic Development Ashley Stolba. 'We are grateful to have AM Batteries in our state, driving groundbreaking technological advancement that benefits our economy and creates high-quality jobs for Massachusetts.' The center was established in large part by the $2.3 million awarded to AM Batteries from the Massachusetts Manufacturing Innovation Initiative (M2I2), a program run by the Massachusetts Technology Collaborative's Center for Advanced Manufacturing. 'The M2I2 program was created to bridge the gap between innovation and commercialization in manufacturing. The opening of this AM Batteries facility is an important milestone in the growth of the Massachusetts advanced manufacturing sector and brings good-paying and sustainable jobs to the Commonwealth,' said Lily Fitzgerald, Director of the Center for Advanced Manufacturing at the MassTech Collaborative. 'Massachusetts is a hub where innovative climatetech companies like AM Batteries can truly flourish,' said Dr. Jennifer LeBlond, Managing Director for Emerging Climatetech at the Massachusetts Clean Energy Center. 'At MassCEC, we're committed to accelerating climate solutions that not only drive down energy costs but also create quality jobs. We're proud to support AM Batteries through our InnovateMass program, as they work to reduce the carbon footprint of battery production, and make clean energy storage more affordable and scalable.' 'WPI is proud to be a partner in the innovation ecosystem that supports companies like AM Batteries,' said Grace Wang, President of WPI. 'It's especially meaningful to see their dry battery electrode technology, which was originally developed at WPI, move toward commercialization. This work reflects our deep commitment to applied research and developing real-world solutions to global challenges in sustainable energy and advanced manufacturing.' About AM Batteries: AM Batteries (AMB), headquartered in Billerica, MA, is at the forefront of dry-electrode manufacturing technology for lithium-ion batteries. Compared to the conventional slurry-casting approach, the company's powder to electrode dry-coating method eliminates the need for harmful solvents and electrode drying, reducing electrode manufacturing CAPEX by up to 30% and OPEX by over 50%. AM Batteries' manufacturing equipment not only reduces the carbon footprint of battery plants by 5x, but also enables higher energy density, faster charging, and more cost-effective batteries. As a turnkey equipment supplier for battery manufacturers, the company is committed to advancing sustainable, high-performance battery manufacturing and building a robust ecosystem around dry coating technology. For more information, visit About the Center for Advanced Manufacturing at MassTech The mission of the Massachusetts Center for Advanced Manufacturing (CAM) is to foster the most complete, collaborative and agile manufacturing ecosystem to enable business growth from innovation through production. CAM is a division of the Massachusetts Technology Collaborative (MassTech), a public economic development agency tasked with supporting business formation and growth in the Commonwealth's tech and innovation sectors. CAM provides a path for manufacturing growth through a connected, accessible ecosystem that supports innovation, workforce development and a business-friendly environment. CAM-managed programs include the Massachusetts Manufacturing Innovation Initiative (M2I2), the MassBridge manufacturing training program and the portal. Learn more at
